All Updates

All Updates

icon
Filter
Product updates
Tealium launches industry-first HIPPA-compliant pharma CDP
Marketing Automation
Jul 25, 2022
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
Product updates
Uber releases five new features for holiday travel season
Travel Tech
Yesterday
Marketing Automation

Marketing Automation

Jul 25, 2022

Tealium launches industry-first HIPPA-compliant pharma CDP

Product updates

  • Tealium, a customer data platform (CDP), launched "Tealium for Pharma," which it claims to be the industry-first CDP solution specialized for pharmaceutical firms that is compliant with patient privacy requirements such as HIPAA.

  • The new solution allows pharmaceutical firms to automatically gather data from varied customer touch points while remaining HIPAA compliant. The platform also has built-in integrations with healthcare provider (HCP) engagement tools and cloud storage providers, including Doceree, Veeva, and DMD in order to deliver personalized customer experiences.  

<ul><li> Analyst QuickTake: Tealium stands out from other CDPs in terms of a large number of integrations its platform is compatible with. The new platform is likely to leverage existing integrations as well as new features such as identity resolution , which is likely to be directly applicable in the context of pharmaceuticals that possess sensitive patient information and must meet HIPPA and other strict compliance rules.</ul>

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.